• Skip to main content
  • Skip to primary sidebar

Sporevia probiotic can reduce staph colonization by more than 95%, study finds

Asia Food Journal
  • Home
  • Latest News
  • Channels
    • Packaging
    • Processing
    • Ingredients
    • Industry
    • Automation
    • Guest Posts
    • Market Trends
  • Subscribe
  • Advertise
  • Event Calendar
  • Contact Us
    • Submit Guest Posts
Share
Leaderboard of Asia Food Journal




Sporevia probiotic can reduce staph colonization by more than 95%, study finds

April 10, 2023 by Asia Food Journal

Sporevia probiotic

A female doctor sits at a table with her colleagues as they conduct a meeting. The doctors are all dressed in scrubs and sitting around inventively listening. The doctor to the right is talking with them about her concerns. Courtesy of Kerry Group

Kerry Group’s probiotic strain Sporevia (Bacillus subtilis MB40) can eliminate Staphylococcus aureus in the human body by more than 95 percent, a clinical trial has found.

Staphylococcus aureus (S. aureus), commonly known as “staph,” is a pathogen that caused over 119,000 infections and nearly 20,000 deaths in the US in 2017.1 ​ ​ However, the use of oral antibiotics for staph decolonization is advised against because of its effect on the gut microbiota and antibiotic resistance.2

Leaderboard of Asia Food Journal

Sporevia (Bacillus subtilis MB40) is a probiotic strain owned by Kerry Group following the licensing agreement with BIO-CAT Microbials in June 2021.

The double-blind, randomized, placebo-controlled trial was conducted following the discovery that Sporevia secretes fengycin, which has been shown to inhibit S. aureus colonization.

One hundred and fifteen adults from Thailand took part in the study, which was funded by the US National Institutes of Health and the National Research Council of Thailand. All were colonized by S. aureus, either in the intestine, nose, or both, but had no history of intestinal disease, antibiotic treatment, or hospital admission within the previous 90 days.2

They received either 250 mg of Sporevia* (10 billion CFU) or placebo once a day for 30 days, after which S. aureus colonization was determined. Oral supplementation with Sporevia resulted in a 96.8 percent reduction of S. aureus in the stool and a 65.4 percent reduction of S. aureus in the nose, whereas there were no significant differences in the placebo groups.

Furthermore, these levels of decolonization were achieved without adverse effects or significant microbiome changes. According to the researchers, the findings indicate a potential for Bacillus subtilis to lower infection rates in vulnerable individuals and in long-term care facilities such as nursing homes.

“We were delighted to have Sporevia selected for this study,” says John Menton, PhD, Senior Product Director, Digestive Health, at Kerry Group. “We have long understood the power of spore-forming probiotics to produce metabolites, enzymes and, depending on the strain, fengycins which may inhibit the growth of deleterious bacteria. In this case the study found that Sporevia produces higher amounts of fengycins than other probiotic strains considered for the study, which made it a great candidate for further research. While we’re not surprised by the conclusions, it’s always great to see hypotheses based on in vitro and animal model data supported by clinical trial results. This study is very encouraging as it demonstrates Sporevia’s potential in bacteria management.”

View the full study at: https://www.thelancet.com/action/showPdf?pii=S2666-5247%2822%2900322-6

* The B. subtilis probiotic formula (Sporevia) was purchased from Kerry Group, but the suppliers did not have any influence on the study design or interpretation.

Find out more about the Kerry ProActive Health portfolio here.

References

1 https://www.cdc.gov/media/releases/2019/p0305-deadly-staph-infections.html

2 Piewngam, P., Khongthong, S., Roekngam, N., Theapparat, Y., Sunpaweravong, S., Faroongsarng, D., & Otto, M. (2023). Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial. The Lancet. Microbe, 4(2), e75–e83.

About Kerry Group 

Kerry is a world leader in taste and nutrition for the food, beverage, and pharmaceutical markets. We innovate with our customers to create great-tasting products with improved nutrition and functionality while ensuring better impact on the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists, and extensive global footprint enable us to solve our customers’ complex challenges with differentiated solutions. At Kerry, we are driven to be our customers’ most valued partner, creating a world of sustainable nutrition, and will reach over two billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com. 

Other Topics: clinical study, Ingredients, Kerry, natural ingredients, Probiotics, sporevia

Related Articles

  • Plant-based snacking

    Courtesy of Planteneers

    The snacking category goes plant-based: Growth through new product ideas 
  • limited edition Pocky durian and Pocky ondeh-ondeh flavours

    Courtesy of Glico

    Pocky launches limited edition Pocky durian and Pocky ondeh-ondeh flavours to celebrate Singapore’s heritage
  • Fi Europe Awards

    Courtesy of Fi Europe

    Fi Europe 2025 Awards entries open
  • Kerry Jakarta officeKerry expands innovation footprint in Southeast Asia with new Jakarta office and RD&A facility
  • Milk fat globule membrane

    Courtesy of Arla Foods Ingredients

    Australia approves Arla Foods Ingredients’ MFGM for use in infant formula
  • CP Bologna with Chilli

    Courtesy of CP Foods

    CP Foods unveils Thailand’s first net-zero food product with Sustainovation – “CP Bologna with Chilli”
Leaderboard of Asia Food Journal

Primary Sidebar

Stay Connected

Your browser does not support the video tag. Learn More

Trending News

  • Kerry Jakarta officeKerry expands innovation footprint in Southeast Asia… Kerry, a global leader in taste and nutrition, officially opened…
  • sustainable sourcingBeverage solutions brand DaVinci Gourmet drives… In a first among global food service beverage brands, DaVinci…
  • Fi Asia Thailand 2025Fi Asia Thailand 2025 registration opens:… Organisers expect a record-breaking showcase of ingredient innovations from 17-19…
  • Singapore’s most beloved local F&B brands revealed: foodpanda unveils first-ever Local Foodie Heroes Hall of FameSingapore’s most beloved local F&B brands… A delicious tribute to Singapore’s iconic local eats to mark…
  • Restaurant Asia 2025Restaurant Asia 2025: F&B industry gathers at… Co-organised by the Restaurant Association of Singapore (RAS) and IEG…
  • Immersive Experience HubIFF expands innovation center in Singapore with new… Immersive Hub to accelerate innovation, deepen customer collaboration, and strengthen…
  • AoFrio iQAoFrio iQ: Unlocking full-fleet intelligence in… AoFrio, a global leader in commercial refrigeration technology, has unveiled…

Subsribe to Our News Letter

Subscribe To
Our Newsletter


By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

© 2025 Harvest Information. All rights reserved. Privacy Policy.

Disclaimer: Translations on this website are automated using Google Translate. While we strive for accuracy, please be cautious, as machine translations may contain errors. For critical or sensitive content, consider seeking professional human translation. We are not liable for any reliance on the translated content.

Become an F&B industry insider

Your go-to resource for all the latest trends, innovations, and news about the food and beverage industry!

 

By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.